Drug Shortage Report for BYETTA

Last updated on 2017-09-07 History
Report ID 18193
Drug Identification Number 02361817
Brand name BYETTA
Common or Proper name exenatide injection
Company Name ASTRAZENECA CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EXENATIDE
Strength(s) 250MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2.4 mL prefilled pen
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-08-14
Actual start date
Estimated end date 2017-09-04
Actual end date 2017-09-06
Shortage status Resolved
Updated date 2017-09-07
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-09-07 English Compare
v5 2017-09-06 French Compare
v4 2017-09-06 English Compare
v3 2017-08-15 English Compare
v2 2017-08-03 French Compare
v1 2017-08-03 English Compare

Showing 1 to 6 of 6